410 related articles for article (PubMed ID: 8613959)
1. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
[TBL] [Abstract][Full Text] [Related]
2. Treatment with antisense oligodeoxynucleotide to a conserved sequence of opioid receptors inhibits antinociceptive effects of delta subtype selective ligands.
Lai J; Bilsky EJ; Porreca F
J Recept Signal Transduct Res; 1995; 15(1-4):643-50. PubMed ID: 8903970
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of [D-Ala2, Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor.
Bilsky EJ; Bernstein RN; Pasternak GW; Hruby VJ; Patel D; Porreca F; Lai J
Life Sci; 1994; 55(2):PL37-43. PubMed ID: 8015351
[TBL] [Abstract][Full Text] [Related]
4. In vivo injection of antisense oligodeoxynucleotides to G alpha subunits and supraspinal analgesia evoked by mu and delta opioid agonists.
Sánchez-Blázquez P; García-España A; Garzón J
J Pharmacol Exp Ther; 1995 Dec; 275(3):1590-6. PubMed ID: 8531133
[TBL] [Abstract][Full Text] [Related]
5. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
[TBL] [Abstract][Full Text] [Related]
6. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception.
Sánchez-Blázquez P; Garzón J
J Pharmacol Exp Ther; 1998 May; 285(2):820-7. PubMed ID: 9580632
[TBL] [Abstract][Full Text] [Related]
7. Enhancement of morphine antinociception by a CCKB antagonist in mice is mediated via opioid delta receptors.
Vanderah TW; Bernstein RN; Yamamura HI; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1996 Jul; 278(1):212-9. PubMed ID: 8764354
[TBL] [Abstract][Full Text] [Related]
8. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
9. Interaction between medullary and spinal delta1 and delta2 opioid receptors in the production of antinociception in the rat.
Hurley RW; Grabow TS; Tallarida RJ; Hammond DL
J Pharmacol Exp Ther; 1999 May; 289(2):993-9. PubMed ID: 10215679
[TBL] [Abstract][Full Text] [Related]
10. Treatment with antisense oligodeoxynucleotide to the opioid delta receptor selectively inhibits delta 2-agonist antinociception.
Lai J; Bilsky EJ; Rothman RB; Porreca F
Neuroreport; 1994 May; 5(9):1049-52. PubMed ID: 8080957
[TBL] [Abstract][Full Text] [Related]
11. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
Mattia A; Vanderah T; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
[TBL] [Abstract][Full Text] [Related]
12. Selective blockade of peripheral delta opioid agonist induced antinociception by intrathecal administration of delta receptor antisense oligodeoxynucleotide.
Bilsky EJ; Wang T; Lai J; Porreca F
Neurosci Lett; 1996 Dec; 220(3):155-8. PubMed ID: 8994216
[TBL] [Abstract][Full Text] [Related]
13. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
[TBL] [Abstract][Full Text] [Related]
14. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
[TBL] [Abstract][Full Text] [Related]
15. Antisense oligodeoxynucleotides to opioid mu and delta receptors reduced morphine dependence in mice: role of delta-2 opioid receptors.
Sánchez-Blázquez P; García-Espãna A; Garzón J
J Pharmacol Exp Ther; 1997 Mar; 280(3):1423-31. PubMed ID: 9067332
[TBL] [Abstract][Full Text] [Related]
16. Differential knockdown of delta-opioid receptor subtypes in the rat brain by antisense oligodeoxynucleotides targeting mRNA.
Negri L; Lattanzi R; Borsodi A; Toth G; Salvadori S
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):203-11. PubMed ID: 10355826
[TBL] [Abstract][Full Text] [Related]
17. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
Cao YJ; Bian JT; Bhargava HN
Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
[TBL] [Abstract][Full Text] [Related]
18. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
19. Agonist and antagonist profiles of [D-Ala2,Glu4]deltorphin and its [Cys4]- and [Ser4]-substituted derivatives: further evidence of opioid delta receptor multiplicity.
Horan PJ; Wild KD; Misicka A; Lipkowski A; Haaseth RC; Hruby VJ; Weber SJ; Davis TP; Yamamura HI; Porreca F
J Pharmacol Exp Ther; 1993 May; 265(2):896-902. PubMed ID: 8388462
[TBL] [Abstract][Full Text] [Related]
20. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
Cahill CM; White TD; Sawynok J
J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]